Celonic Group and CARBOGEN AMCIS announce partnership to deliver fully integrated ADC development and manufacturing platform
Strategic alliance means a seamless, end‑to‑end ADC path — from cell line to commercial fill‑finish — under one coordinated platform
16 Oct 2025
Dr. Samanta Cimitan, CEO of Celonic Group and Stephan Fritschi, CEO of Carbogen Amcis Group
Celonic Group and CARBOGEN AMCIS Group have announced a strategic partnership to offer a fully integrated antibody-drug conjugate (ADC) development and manufacturing solution. The alliance combines Celonic’s advanced biologics capabilities with CARBOGEN AMCIS’s expertise in payload synthesis, conjugation, and sterile fill-finish, creating a seamless, end-to-end platform for ADC innovators.
This partnership addresses a critical need in the biopharmaceutical sector, where the complexity of ADC development often necessitates collaboration between multiple vendors. By combining their strengths, Celonic and CARBOGEN AMCIS aim to streamline the supply chain, speed up timelines, and support clients from early-stage development through to commercial launch.
The integrated offering includes:
- Cell line development and antibody production at scale (Celonic)
- Payload and linker synthesis and at scale manufacturing (CARBOGEN AMCIS)
- ADC conjugation and sterile fill-finish (CARBOGEN AMCIS)
- Regulatory support and CMC documentation for IND, IMPD, and BLA filings
“This strategic alliance is a direct response to the evolving needs of ADC innovators,” said Dr. Samanta Cimitan, CEO of Celonic Group. “By integrating Celonic’s advanced biologics platforms with CARBOGEN AMCIS’s world-class payload and conjugation capabilities, we’re enabling a fully harmonized development and manufacturing pathway, from DNA to drug product. It’s a scalable, compliant, and commercially ready solution designed to accelerate innovation and reduce complexity for our partners.”
“The new targeted cancer treatments have fueled a rising demand for ADCs, and this alliance positions us to meet that demand with unmatched technical expertise and operational agility,” said Stephan Fritschi, CEO of Carbogen Amcis Group. “Together, we offer a comprehensive service for ADC development, streamlined, scalable, and globally compliant.”